AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-0.76 Cr | ₹-14 Cr | ₹13 Cr | ₹2.04 Cr | ₹2.13 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AARTI DRUGS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-0.76 Cr |
Mar2023 | ₹-14 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹2.04 Cr |
Mar2020 | ₹2.13 Cr |
How is Net Cash Inflow / Outflow of AARTI DRUGS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-0.76 Cr | Negative | |
Mar2023 | ₹-14 Cr | Negative | |
Mar2022 | ₹13 Cr | 526.79 | |
Mar2021 | ₹2.04 Cr | -4.04 | |
Mar2020 | ₹2.13 Cr | - |
Compare Net Cash Inflow / Outflow of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹3,695.8 Cr | -2.4% | -4.2% | -22.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | -2% | -0.8% | 16.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | -2.7% | 3.5% | 66.7% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 0.7% | 1.4% | 3.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 0.1% | -8.5% | 0.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | -0.9% | -1% | 24% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -2.4% |
-4.2% |
-22.3% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses